Compare peptides
Put two entries side by side — evidence, mechanism, risks, and community claims.
HGH Fragment 176-191
Preclinical
Research chemical
Summary
C-terminal hGH fragment marketed for lipolysis; closely related to AOD-9604 discussions.
Categories
Metabolic & Body Comp
Mechanism
Proposed selective lipolytic signaling without full GH anabolic cascade.
Half-life
Short
Routes
Subcutaneous injection
Legal / access
Research chemical; not an approved weight-loss drug.
Key risks
- Injection irritation
- Unknown durability of effect
Common claims
- Enhanced fat oxidation
- Cutting stack ingredient
Select peptide B